Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -23,147.83%-10.69M | 127.52%5.18M | -4,211.70%-7.03M | -202.86%-3.07M | -315.02%-5.47M | -106.32%-46K | 138.27%2.28M | -89.70%171K | 14.08%-1.01M | 665.96%2.54M |
| Net income from continuing operations | 2.79%-15.71M | -277.29%-15.1M | -17.09%-18.92M | -28.06%-48.89M | -24.64%-12.57M | -54.26%-16.16M | 43.55%-4M | -53.53%-16.16M | 15.52%-38.17M | 7.97%-10.08M |
| Operating gains losses | -303.68%-3.29M | 69.32%-108K | -240.41%-1.73M | -952.63%-800K | -1,973.91%-862K | -419.75%-816K | -1,166.67%-352K | 61,400.00%1.23M | 97.97%-76K | 202.22%46K |
| Depreciation and amortization | -37.37%3.7M | -9.51%6.5M | -0.27%5.51M | 15.55%24.09M | 0.04%5.47M | 17.04%5.91M | 37.86%7.18M | 7.95%5.52M | -2.30%20.85M | 11.27%5.47M |
| Asset impairment expenditure | 2,645.28%1.46M | --1.2M | -11.12%727K | -83.18%1.3M | -93.45%428K | -91.40%53K | --0 | 154.04%818K | -64.72%7.73M | 18.22%6.54M |
| Remuneration paid in stock | -135.71%-10K | 88.89%-1K | -37.04%17K | -104.26%-4K | -394.12%-50K | 133.33%28K | -128.13%-9K | -18.18%27K | --94K | 141.46%17K |
| Remuneration paid in stock | 1,365.10%2.81M | 1,171.82%2.8M | 1,429.73%3.4M | -28.34%1.45M | 81.42%820K | -40.92%192K | -42.26%220K | -74.51%222K | -26.11%2.03M | -5.44%452K |
| Deferred tax | 254.55%702K | -57.69%121K | -86.67%-28K | 132.96%679K | 104.87%210K | 1,900.00%198K | -86.21%286K | -107.89%-15K | -155.41%-2.06M | -696.54%-4.31M |
| Other non cashItems | 53.12%12.92M | 37.75%5.85M | 183.63%9.46M | 72.68%16.21M | -96.09%195K | 1,017.48%8.44M | 1,818.22%4.24M | -14.42%3.34M | 15,290.16%9.39M | 191.57%4.98M |
| Change In working capital | -730.04%-13.28M | 174.26%3.93M | -205.38%-5.47M | 466.03%2.89M | 256.64%885K | -54.30%2.11M | 19.66%-5.29M | 196.06%5.19M | 60.90%-789K | 71.48%-565K |
| -Change in receivables | -104.09%-172K | 96.08%-137K | -338.99%-3.16M | 15.30%2.38M | 107.55%346K | -48.29%4.21M | -3.13%-3.49M | -30.33%1.32M | 161.78%2.07M | 35.72%-4.58M |
| -Change in inventory | -259.00%-3.51M | -313.88%-1.06M | 402.71%1.67M | -2.42%-3.35M | -578.01%-2.31M | 33.51%-978K | 125.91%497K | 66.99%-553K | -22.68%-3.27M | 78.16%-341K |
| -Change in prepaid assets | -182.57%-308K | -36.96%-1.07M | -6.21%393K | -117.68%-35K | -42.88%437K | 71.39%-109K | -13.83%-782K | -16.37%419K | 132.78%198K | 0.53%765K |
| -Change in payables and accrued expense | -815.58%-9.28M | 509.78%6.2M | -209.40%-4.38M | 1,716.36%3.89M | -32.80%2.41M | 39.50%-1.01M | 44.62%-1.51M | 288.35%4M | -95.34%214K | -39.59%3.59M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -23,147.83%-10.69M | 127.52%5.18M | -4,211.70%-7.03M | -202.86%-3.07M | -315.02%-5.47M | -106.32%-46K | 138.27%2.28M | -89.70%171K | 14.08%-1.01M | 665.96%2.54M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -171.20%-11M | -116.83%-10.21M | -36.32%-6.56M | -3.95%-18.85M | -68.15%-5.28M | 8.09%-4.06M | 2.34%-4.71M | 16.50%-4.81M | 7.49%-18.13M | 46.32%-3.14M |
| Capital expenditure reported | -171.22%-11M | -116.83%-10.21M | -57.03%-7.56M | 5.47%-18.85M | -29.45%-5.28M | 9.32%-4.06M | 16.39%-4.71M | 16.50%-4.81M | -1.73%-19.94M | 30.27%-4.08M |
| Net other investing changes | --1K | --0 | --997K | ---- | ---- | ---- | ---- | ---- | --1.81M | --938K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -171.20%-11M | -116.83%-10.21M | -36.32%-6.56M | -3.95%-18.85M | -68.15%-5.28M | 8.09%-4.06M | 2.34%-4.71M | 16.50%-4.81M | 7.49%-18.13M | 46.32%-3.14M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -128.53%-2.39M | 3,447.55%59.99M | -28.29%3.87M | 70.94%35.12M | 607.38%19.64M | 281.98%8.39M | -82.97%1.69M | -4.29%5.4M | 17.83%20.55M | -55.61%2.78M |
| Net issuance payments of debt | -118.17%-1.52M | 14,499.71%50.08M | 319.75%340K | -52.76%4.17M | -202.84%-4.6M | 500.14%8.34M | -92.88%343K | -95.00%81K | 494.94%8.82M | 184.95%4.47M |
| Net common stock issuance | 13,335.71%1.88M | 4,845.63%13.01M | -31.27%3.57M | 1,449.71%47.7M | 281,653.33%42.23M | -98.19%14K | --263K | 123.90%5.19M | -84.53%3.08M | -100.59%-15K |
| Proceeds from stock option exercised by employees | --1.83M | --1.23M | --3.69M | --620K | --620K | --0 | --0 | --0 | --0 | ---- |
| Net other financing activities | -11,864.10%-4.59M | -498.71%-4.33M | -2,960.77%-3.72M | -306.19%-17.37M | -880.57%-18.62M | -98.89%39K | -78.78%1.09M | -92.37%130K | 3,843.56%8.42M | -188.12%-1.9M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -128.53%-2.39M | 3,447.55%59.99M | -28.29%3.87M | 72.81%35.12M | 668.87%19.64M | 281.98%8.39M | -82.97%1.69M | -4.29%5.4M | 16.56%20.32M | -59.16%2.55M |
| Net cash flow | ||||||||||
| Beginning cash position | 1,595.99%61.68M | 124.15%8.75M | 870.50%20M | 4.94%2.06M | 710.67%7.22M | 123.54%3.64M | 15.06%3.9M | 4.94%2.06M | -32.28%1.96M | -63.01%890K |
| Current changes in cash | -661.29%-24.09M | 7,516.87%54.96M | -1,380.50%-9.72M | 1,020.80%13.2M | 353.78%8.89M | 388.57%4.29M | 11.15%-741K | -50.68%759K | 135.23%1.18M | 164.15%1.96M |
| Effect of exchange rate changes | 310.66%1.5M | -527.64%-2.03M | -241.33%-1.53M | 538.30%4.74M | 593.41%3.89M | -195.07%-713K | 150.86%474K | 1,085.45%1.08M | -144.89%-1.08M | 33.36%-789K |
| End cash Position | 441.93%39.1M | 1,595.99%61.68M | 124.15%8.75M | 870.50%20M | 870.50%20M | 710.67%7.22M | 123.54%3.64M | 15.06%3.9M | 4.94%2.06M | 4.94%2.06M |
| Free cash from | -428.94%-21.69M | -106.83%-5.03M | -214.28%-14.59M | -4.60%-21.92M | -601.24%-10.74M | -9.54%-4.1M | 78.99%-2.43M | -13.11%-4.64M | -0.83%-20.95M | 72.21%-1.53M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.